Cell death-mediated cleavage of the attraction signal p43 in human atherosclerosis: Implications for plaque destabilization

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 7, 2010, Pages 1415-1422

  Martinet, Wim ^a   De Meyer, Inge ^a   Cools, Nathalie ^a   Timmerman, Vincent ^a   Bult, Hidde ^a   Bosmans, Johan ^b   De Meyer, Guido R Y ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

apoptosis; atherosclerosis; cell death; inflammation; p43

Indexed keywords

CALPAIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; PROTEIN P43; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CELL DEATH; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; CALPAIN; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CELLS, CULTURED; CORONARY ARTERY DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICE; MICE, KNOCKOUT; MONOCYTES; MYOCYTES, SMOOTH MUSCLE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOPROTEINS; RNA, MESSENGER; RNA-BINDING PROTEINS; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 77953957906     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.206029     Document Type: Article

References (37)

1. Kockx MM, De Meyer GRY, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97:2307-2315.
2. Clarke MC, Littlewood TD, Figg N, Maguire JJ, Davenport AP, Goddard M, Bennett MR. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res. 2008;102:1529-1538.
3. Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol. 2008;3:99-126.
4. Kao J, Houck K, Fan Y, Haehnel I, Libutti SK, Kayton ML, Grikscheit T, Chabot J, Nowygrod R, Greenberg S, Kuang W-J, Leung DW, Hayward JR, Kisiel W, Heath M, Brett J, Stern DM. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem. 1994;269:25106-25119.
5. van Horssen R, Eggermont AMM, ten Hagen TLM. Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiolog-ical processes. Cytokine Growth Factor Rev. 2006;17:339-348.
6. Quevillon S, Agou F, Robinson JC, Mirande M. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J Biol Chem. 1997;272:32573-32579.
7. Park SG, Jung KH, Lee JS, Jo YJ, Motegi H, Kim S, Shiba K. Precursor of pro-apoptotic cytokine modulates aminoacylation activity of tRNA synthetase. J Biol Chem. 1999;274:16673-16676.
8. Kim Y, Shin J, Li R, Cheong C, Kim K, Kim S. A novel anti-tumor cytokine contains an RNA binding motif present in aminoacyl-tRNA synthetases. J Biol Chem. 2000;275:27062-27068.
9. Wolin SL, Matera AG. The trials and travels of tRNA. Genes Dev. 1999;13:1-10.
10. Kleeman TA, Wei D, Simpson KL, First EA. Human tyrosyl-tRNA synthetase shares amino acid sequence homology with a putative cyto-kine. J Biol Chem. 1997;272:14420-14425.
11. Knies UE, Behrensdorf HA, Mitchell CA, Deutsch U, Risau W, Drexler HC, Clauss M. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc Natl Acad Sci USA. 1998;95: 12322-12327.
12. Matschurat S, Knies UE, Person V, Fink L, Stoelcker B, Ebenebe C, Behrensdorf HA, Schaper J, Clauss M. Regulation of EMAP II by hypoxia. Am J Pathol. 2003;162:93-103.
13. Behrensdorf HA, van de Craen M, Knies UE, Vandenabeele P, Clauss M. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7. FEBS Lett. 2000;466:143-147.
14. Zhang FR, Schwarz MA. Pro-EMAP II is not primarily cleaved by caspase-3 and-7. Am J Physiol Lung Cell Mol Physiol. 2002;282: L1239-L1244.
15. Ko YG, Park H, Kim T, Lee JW, Park SG, Seol W, Kim JE, Lee WH, Kim SH, Park JE, Kim S. A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J Biol Chem. 2001;276: 23028-23033.
16. Shalak V, Guigou L, Kaminska M, Wautier MP, Wautier JL, Mirande M. Characterization of p43(ARF), a derivative of the p43 component of multiaminoacyl-tRNA synthetase complex released during apoptosis. J Biol Chem. 2007;282:10935-10943.
17. Martinet W, Croons V, Timmermans JP, Herman AG, De Meyer GRY. Nitric oxide selectively depletes macrophages in atherosclerotic plaques via induction of endoplasmic reticulum stress. Br J Pharmacol. 2007; 152:493-500.
18. Warny M, Kelly CP. Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteases. Am J Physiol. 1999;276: C717-C724.
19. Martinet W, De BM, Schrijvers DM, De Meyer GR, Herman AG, Kockx MM. 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24:2296-2301.
20. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009;461:282-286.
21. Schwarz MA, Kandel J, Brett J, Li J, Hayward J, Schwarz RE, Chappey O, Wautier JL, Chabot J, Lo Gerfo P, Stern D. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J Exp Med. 1999;190:341-354.
22. Berger AC, Alexander HR, Tang G, Wu PS, Hewitt SM, Turner E, Kruger E, Figg WD, Grove A, Kohn E, Stern D, Libutti SK. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc Res. 2000;60:70-80.
23. Wellings RP, Lash GE, Murray JC, Tas M, Ward W, Trew AJ, Baker PN. Endothelial monocyte-activating polypeptide-2 is increased in pregnancy
24. but is not further increased in preeclampsia. J Soc Gynecol Investig. 1999;6:142-146.
25. Sen E, Ulger F, Kaya A, Akar N, Gonullu U. Serum endothelial monocyte-activating polypeptide-II: a novel biomarker in patients with non-small-cell lung cancer. Clin Lung Cancer. 2008;9:166-170.
26. Yao C, Williams AJ, Ottens A, Lu XC, Liu MC, Hayes RL, Wang KK, Tortella FC, Dave JR. p43/pro-EMAP-II: a potential biomarker for discriminating traumatic versus ischemic brain injury. J Neurotrauma. 2009;in press.
27. Daemen MA, van't Veer C, Denecker G, Heemskerk VH, Wolfs TGAM, Clauss M, Vandenabeele P, Buurman WA. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 1999;104:541-549.
28. Murray JC, Barnett G, Tas M, Jakobsen A, Brown J, Powe D, Clelland C. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo. Am J Pathol. 2000;157:2045-2053.
29. Hou Y, Plett PA, Ingram DA, Rajashekhar G, Orschell CM, Yoder MC, March KL, Clauss M. Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. Exp Hematol. 2006;34:1125-1132.
30. Norcum MT, Warrington JA. The cytokine portion of p43 occupies a central position within the eukaryotic multisynthetase complex. J Biol Chem. 2000;275:17921-17924.
31. Wolfe CL, Warrington JA, Davis S, Green S, Norcum MT. Isolation and characterization of human nuclear and cytosolic multisynthetase complexes and the intracellular distribution of p43/EMAPII. Protein Sci. 2003;12:2282-2290.
32. Bottoni A, Vignali C, Piccin D, Tagliati F, Luchin A, Zatelli MC, Uberti EC. Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. J Cell Physiol. 2007;212:293-297.
33. Liu J, Schwarz MA. Identification of protease-sensitive sites in human endothelial-monocyte activating polypeptide II protein. Exp Cell Res. 2006;312:2231-2237.
34. Johnson DE. Noncaspase proteases in apoptosis. Leukemia. 2000;14: 1695-1703.
35. Ishidoh K, Kominami E. Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun. 1995;217:624-631.
36. Park SG, Shin H, Shin YK, Lee Y, Choi EC, Park BJ, Kim S. The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair. Am J Pathol. 2005;166:387-398.
37. Martinet W, Verheye S, De Meyer GRY. Selective depletion of macro-phages in atherosclerotic plaques via macrophage-specific initiation of cell death. Trends Cardiovasc Med. 2007;17:69-75.